Etidocaine Hydrochloride

盐酸依替卡因

Report date: 2022/02/09 09:21:02
NME

Base Information

Drug NameEtidocaine Hydrochloride
Drug Alias NameEtidocainum益替多卡因依替卡因盐酸盐DuranestW-19053
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSodium channel alpha subunit blockers
TargetsSodium channel alpha subunit
Therapy Area/IndicationsAnesthesia
Global Approved IndicationsAnesthesia
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1976/08/30
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesAstrazeneca Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAstrazeneca Plc
Active IndicationsN/A
Inactive IndicationsAnesthesia

Other Information

ATC CodeN01BB07
Related LinksWikipediaDrugBankKEGG